BRIEF published on 07/15/2025 at 09:05, 8 months 25 days ago AATec Medical et Northway Biotech forment un partenariat pour le développement de la production d'ATL-105 Partenariat ATL-105 Fabrication De Produits Biologiques Maladies Pulmonaires Thérapie Respiratoire
BRIEF published on 07/15/2025 at 09:05, 8 months 25 days ago AATec Medical and Northway Biotech Form Partnership for ATL-105 Production Development Partnership ATL-105 Biologics Manufacturing Lung Diseases Respiratory Therapy
PRESS RELEASE published on 07/15/2025 at 09:00, 8 months 25 days ago AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Diseases AATec Medical and Northway Biotech announce partnership to develop industrial production process for ATL-105 targeting lung diseases Partnership AATec Medical ATL-105 Lung Diseases Northway Biotech
BRIEF published on 04/15/2025 at 11:09, 11 months 24 days ago AATec Medical obtient 4 millions d'euros pour le développement de médicaments respiratoires Biotechnologie Financement Essais Cliniques Développement De Médicaments Maladies Respiratoires
BRIEF published on 04/15/2025 at 11:09, 11 months 24 days ago AATec Medical Secures EUR 4 Million for Respiratory Drug Development Biotechnology Funding Clinical Trials Drug Development Respiratory Diseases
PRESS RELEASE published on 04/15/2025 at 11:04, 11 months 24 days ago AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development AATec Medical secures EUR 4 million funding to advance lead respiratory drug candidate, ATL-105, for clinical development to treat non-CF bronchiectasis by 2026 Clinical Development AATec Medical Non-CF Bronchiectasis EUR 4 Million Respiratory Drug Candidate
BRIEF published on 09/18/2024 at 10:05, 1 year 6 months ago AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board Scientific Advisory Board AATec Medical James Chalmers Bronchiectasis Recombinant AAT
BRIEF published on 09/18/2024 at 10:05, 1 year 6 months ago AATec Medical accueille le professeur James Chalmers au sein de son conseil consultatif scientifique AATec Medical Conseil Consultatif Scientifique James Chalmers Bronchectasie AAT Recombinante
PRESS RELEASE published on 09/18/2024 at 10:00, 1 year 6 months ago AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board AATec Medical welcomes Professor James Chalmers, a renowned expert in respiratory medicine, to its Scientific Advisory Board to advance product development in non-CF bronchiectasis Scientific Advisory Board AATec Medical Professor James Chalmers Respiratory Medicine Non-CF Bronchiectasis
BRIEF published on 07/24/2024 at 10:05, 1 year 8 months ago AATec Medical Makes Significant Strides in First Year of Operations Biotechnology Clinical Trials AATec Medical ATL-105 Inflammatory Lung Diseases
Published on 04/10/2026 at 00:00, 16 minutes ago Redwood AI Announces Upgraded Cloud-Based Reactosphere Platform with Enhanced Security and Expanded Core Capabilities
Published on 04/09/2026 at 23:15, 1 hour 1 minute ago Digi Power X Enters into Amended and Restated Sales Agreement
Published on 04/09/2026 at 23:00, 1 hour 16 minutes ago Apex Critical Metals to Attend Critical Materials Conference: Aerospace & Defence in Washington, DC
Published on 04/09/2026 at 19:15, 5 hours 1 minute ago Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 22:00, 2 hours 16 minutes ago Invitation - First Quarter 2026 Trading Update Conference Call
Published on 04/09/2026 at 21:01, 3 hours 15 minutes ago GEVELOT S.A.: PRESS RELEASE CLOSING OF 2025 ACCOUNTS
Published on 04/09/2026 at 21:01, 3 hours 15 minutes ago GEVELOT S.A.: COMMUNIQUE ARRETE DES COMPTES 2025
Published on 04/09/2026 at 20:03, 4 hours 13 minutes ago Annual General Meeting approves all proposals
Published on 04/09/2026 at 18:45, 5 hours 31 minutes ago EUROPLASMA: Tirage de 200 obligations convertibles en actions nouvelles pour un montant nominal de 1M€
Published on 04/09/2026 at 20:00, 4 hours 16 minutes ago SMTPC - Communiqué sur le Chiffre d'affaires du 1er trimestre 2026
Published on 04/09/2026 at 18:35, 5 hours 41 minutes ago Mise à disposition des documents préparatoires à l'Assemblée Générale Mixte du 30 avril 2026
Published on 04/09/2026 at 18:35, 5 hours 41 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
